Vol 94, No 4 (2023)
Research paper
Published online: 2023-03-16
CoronaVac vaccine does not affect ovarian reserve
1
, 2, 1, 1, 1
, 2, 1, 1, 1
Abstract
Objectives: In this study, our aim is to investigate the effect of CoronaVac vaccine on ovarian reserve in female patients followed up for infertility.
Material and methods: Our study is a retrospective study. Forty-six infertile patients who received two doses of CoronaVac vaccine one month apart and had not had a previous Covid 19 infection were included in the study. Anti-müllerian hormone (AMH) and folliculometry of 46 patients one month before CoronaVac vaccine and one month after the second dose of vaccine were compared.
Results: There was no statistically significant difference in the change of AMH level and follicle number before and after vaccination (respectively p = 0.366; 0.610).
Conclusions: Considering that having a COVID-19 infection has a negative effect on female fertility and causing ovarian damage in recent studies, vaccination is a rational and cost-effective approach to protect ovarian reserve. Knowing that the vaccine does not have a negative effect on fertility may increase the application of the vaccine in women of reproductive age.
Keywords: anti mullerian hormoneCoronaVacinfertilityovarian folliclevaccination
References
- Wang C, Horby PW, Hayden FG, et al. A novel coronavirus outbreak of global health concern. Lancet. 2020; 395(10223): 470–473.
- Zhu Na, Zhang D, Wang W, et al. China Novel Coronavirus Investigating and Research Team. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020; 382(8): 727–733.
- World Health Organization. Virtual press conference on COVID-19 – 11 March 2020. https://www.who.int/docs/default-source/coronaviruse/transcripts/who-audio-emergencies-coronavirus-press-conference-full-and-final-11mar2020.pdf (28.01.2022).
- Salzberger B, Buder F, Lampl B, et al. Epidemiology of SARS-CoV-2 infection and COVID-19. Internist (Berl). 2020; 61(8): 782–788.
- World Health Organization. Draft landscape of COVID-19 candidate vaccines. https://www.who.int/blueprint/priority-diseases/key-action/novel-coronavirus-landscape-ncov.pdf (28.01.2022).
- Zhang Y, Zeng G, Pan H, et al. Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18-59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial. Lancet Infect Dis. 2021; 21(2): 181–192.
- Wu Z, Hu Y, Xu M, et al. Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy adults aged 60 years and older: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial. Lancet Infect Dis. 2021; 21(6): 803–812.
- Mallapaty S. China COVID vaccine reports mixed results — what does that mean for the pandemic? Nature. 2021 [Epub ahead of print].
- Scully EP, Haverfield J, Ursin RL, et al. Considering how biological sex impacts immune responses and COVID-19 outcomes. Nat Rev Immunol. 2020; 20(7): 442–447.
- Tesarik J. After corona: there is life after the pandemic. Reprod Biomed Online. 2020; 40(6): 760–762.
- Wang Z, Xu X. scRNA-seq profiling of human testes reveals the presence of the ACE2 receptor, a target for SARS-CoV-2 infection in spermatogonia, leydig and sertoli cells. Cells. 2020; 9(4).
- Wang T, Du Z, Zhu F, et al. Comorbidities and multi-organ injuries in the treatment of COVID-19. Lancet. 2020; 395(10228): e52.
- Mao L, Jin H, Wang M, et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 2020; 77(6): 683–690.
- Ali N. Relationship between COVID-19 infection and liver injury: a review of recent data. Front Med (Lausanne). 2020; 7: 458.
- Chu H, Bai T, Chen L, et al. Multicenter analysis of liver injury patterns and mortality in COVID-19. Front Med (Lausanne). 2020; 7: 584342.
- Li R, Yin T, Fang F, et al. Potential risks of SARS-CoV-2 infection on reproductive health. Reprod Biomed Online. 2020; 41(1): 89–95.
- Li K, Chen Ge, Hou H, et al. Analysis of sex hormones and menstruation in COVID-19 women of child-bearing age. Reprod Biomed Online. 2021; 42(1): 260–267.
- Ding T, Wang T, Zhang J, et al. Analysis of ovarian injury associated with COVID-19 disease in reproductive-aged women in Wuhan, China: an observational study. Front Med (Lausanne). 2021; 8: 635255.
- Hansen KR, Knowlton NS, Thyer AC, et al. A new model of reproductive aging: the decline in ovarian non-growing follicle number from birth to menopause. Hum Reprod. 2008; 23(3): 699–708.
- Practice Committee of the American Society for Reproductive Medicine. Electronic address: asrm@asrm.org, Practice Committee of the American Society for Reproductive Medicine. Testing and interpreting measures of ovarian reserve: a committee opinion. Fertil Steril. 2020; 114(6): 1151–1157.
- Kurmanova AM, Kurmanova GM, Lokshin VN. Reproductive dysfunctions in viral hepatitis. Gynecol Endocrinol. 2016; 32(sup2): 37–40.
- Schoenbaum EE, Hartel D, Lo Y, et al. HIV infection, drug use, and onset of natural menopause. Clin Infect Dis. 2005; 41(10): 1517–1524.
- Kallio ER, Helle H, Koskela E, et al. Age-related effects of chronic hantavirus infection on female host fecundity. J Anim Ecol. 2015; 84(5): 1264–1272.
- Stanley KE, Thomas E, Leaver M, et al. Coronavirus disease-19 and fertility: viral host entry protein expression in male and female reproductive tissues. Fertil Steril. 2020; 114(1): 33–43.
- Fu J, Zhou B, Zhang L, et al. Expressions and significances of the angiotensin-converting enzyme 2 gene, the receptor of SARS-CoV-2 for COVID-19. Mol Biol Rep. 2020; 47(6): 4383–4392.
- Illiano E, Trama F, Costantini E. Could COVID-19 have an impact on male fertility? Andrologia. 2020; 52(6): e13654.
- Khalili MA, Leisegang K, Majzoub A, et al. Male fertility and the COVID-19 pandemic: systematic review of the literature. World J Mens Health. 2020; 38(4): 506–520.
- Berenson AB, Chang M, Hirth JM, et al. Intent to get vaccinated against COVID-19 among reproductive-aged women in Texas. Hum Vaccin Immunother. 2021; 17(9): 2914–2918.
- Orvieto R, Noach-Hirsh M, Segev-Zahav A, et al. Does mRNA SARS-CoV-2 vaccine influence patients' performance during IVF-ET cycle? Reprod Biol Endocrinol. 2021; 19(1): 69.
- Bowman CJ, Bouressam M, Campion SN, et al. Lack of effects on female fertility and prenatal and postnatal offspring development in rats with BNT162b2, a mRNA-based COVID-19 vaccine. Reprod Toxicol. 2021; 103: 28–35.
